Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer

Autor: IAFFAIOLI RV, FORMATO R, TORTORIELLO A, DEL PRETE S, PAPPAGALLO G, PISANO A, GEBBIA V, FANELLI F, IANNIELLO G, CIGOLARI S, PIZZA C, MARANO O, PEZZELLA G, PEDICINI T, FEBBRARO A, INCORONATO P, MANZIONE L, FERRARI E, MARZANO N, QUATTRIN S, PISCONTI S, NASTI G, GIOTTA G, COLUCCI G, SOUTHERN ITALY ONCOLOGY GROUP, CARAGLIA, Michele

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3977::02110b7a43b488389f4d0794ffc25c68
http://hdl.handle.net/11591/195021

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Weekly Docetaxel and Vinorelbine (VIN-DOX) as First Line Treatment in Patients with Hormone Refractory Prostate Cancer

Autor: Carmine Pizza, Vincenzo Altieri, Giampaolo Tortora, Ombretta Marano, Riccardo Autorino, Adele D’Alessio, Michele De Laurentiis, Angelo Raffaele Bianco, Sisto Perdonà, Giuseppe Di Lorenzo, Giuseppe Cancello, Sabino De Placido

Publikováno v: European Urology. 46:712-716

Background: The current study investigated the clinical benefit, the impact on biochemical and objective response and tolerability of weekly docetaxel with vinorelbine (VIN-DOX) in symptomatic patients with hormone refractory prostate cancer (HRPC).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc088139876a41df4c48ccec9cf1e94b
https://doi.org/10.1016/j.eururo.2004.08.022

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.

Autor: Riccardi F; Breast Unit, A. Cardarelli Hospital, I-80131 Naples, Italy., Colantuoni G; Medical Oncology, San Giuseppe Moscati Hospital, I-83100 Avellino, Italy., Diana A; Division of Medical Oncology, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', I-80131 Naples, Italy., Mocerino C; Breast Unit, A. Cardarelli Hospital, I-80131 Naples, Italy., Cartenì G; Breast Unit, A. Cardarelli Hospital, I-80131 Naples, Italy., Lauria R; Medical Oncology, Department of Clinical Medicine and Surgery, University of Naples Federico II, I-80131 Naples, Italy., Febbraro A; Medical Oncology, Sacro Cuore di Gesù Fatebenefratelli Hospital, I-82100 Benevento, Italy., Nuzzo F; Breast Cancer Unit, Cancer Institute G. Pascale Foundation, I-80131 Naples, Italy., Addeo R; Medical Oncology, Frattamaggiore Hospital, I-80027 Frattamaggiore, Italy., Marano O; Medical Oncology, Santa Maria della Pietà Hospital, I-80035 Nola, Italy., Incoronato P; Medical Oncology, ASL Napoli 2 Nord Hospital, I-80014 Giugliano, Italy., De Placido S; Medical Oncology, Department of Clinical Medicine and Surgery, University of Naples Federico II, I-80131 Naples, Italy., Ciardiello F; Division of Medical Oncology, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', I-80131 Naples, Italy., Orditura M; Division of Medical Oncology, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', I-80131 Naples, Italy.

Publikováno v: Molecular and clinical oncology [Mol Clin Oncol] 2018 Sep; Vol. 9 (3), pp. 255-263. Date of Electronic Publication: 2018 Jul 16.